615-37-2 + 115290-81-8 = 82248-59-7 反应条件:1.1 Reagents: Cesium Carbonate Catalysts: Cuprous Iodide Solvents: Xylene; 130 °C1.2 Reagents: Hydrochloric Acid Solvents: Isopropanol,Tert-Butyl Methyl Ether; 0 - 5 °C 标题:Efficient Method For Preparing 3-Aryloxy-3-Arylpropylamines And Their Optical Stereoisomers 参考文献:Canada]
115290-81-8 = 82248-59-7 [标题:Reaction Conditions 标题:A Site Isolation-Enabled Organocatalytic Approach To Enantiopure γ-Amino Alcohol Drugs 作者:Wang,Shoulei; Et Al 参考文献:Tetrahedron 日期:2018 卷标:74(29) 页码:3943-3946]
100306-34-1 = 82248-59-7 反应条件:1.1 Reagents: Triphenylphosphine,Diethyl Azodicarboxylate Solvents: Tetrahydrofuran; 24 H,20 °C2.1 Solvents: Ethanol,Water; 12 H,30 °C2.2 Reagents: Hydrochloric Acid Solvents: Water 标题:The Synthesis Of Atomoxetine-Containing Carboxamides - Potential Human Carbonic Anhydrase Inhibitors 作者:Shetnev,Anton A.; Et Al 参考文献:American Chemical Science Journal 日期:2016 卷标:10(3) 页码:1-5]
100306-34-1 = 82248-59-7 反应条件:1.1 Reagents: Triphenylphosphine,Diethyl Azodicarboxylate Solvents: Tetrahydrofuran2.1 Solvents: Ethanol,Water2.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether 标题:Chiral Synthesis Via Organoboranes. 18. Selective Reductions. 43. Diisopinocampheylchloroborane As An Excellent Chiral Reducing Reagent For The Synthesis Of Halo Alcohols Of High Enantiomeric Purity. A Highly Enantioselective Synthesis Of Both Optical Isomers Of Tomoxetine,Fluoxetine,And Nisoxetine 作者:Srebnik,Morris; Et Al 参考文献:Journal Of Organic Chemistry 日期:1988 卷标:53(13) 页码:2916-20]
83015-26-3 = 82248-59-7 反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Diethyl Ether 标题:An Improved Method For The Synthesis Of Optically Active Tomoxetines And Fluoxetines 作者:Xu,Cheng-Fu; Et Al 参考文献:Chinese Journal Of Chemistry 日期:2004 卷标:22(8) 页码:775-778]
114446-47-8 = 82248-59-7 反应条件:1.1 Solvents: Ethanol,Water1.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether 标题:Chiral Synthesis Via Organoboranes. 18. Selective Reductions. 43. Diisopinocampheylchloroborane As An Excellent Chiral Reducing Reagent For The Synthesis Of Halo Alcohols Of High Enantiomeric Purity. A Highly Enantioselective Synthesis Of Both Optical Isomers Of Tomoxetine,Fluoxetine,And Nisoxetine 作者:Srebnik,Morris; Et Al 参考文献:Journal Of Organic Chemistry 日期:1988 卷标:53(13) 页码:2916-20]
114446-47-8 = 82248-59-7 反应条件:1.1 Solvents: Water; 3 H,130 °C; 130 °C -> Rt1.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether,Water; Rt 标题:A New Method For Synthesis Of Atomoxetine And Its Interaction With Azole-Containing Sulfonyl Chlorides 作者:Korsakov,M. K.; Et Al 参考文献:Zhurnal Organichnoi Ta Farmatsevtichnoi Khimii 日期:2013 卷标:11(4) 页码:38-41]
114446-47-8 = 82248-59-7 反应条件:1.1 Solvents: Ethanol,Water; 12 H,30 °C1.2 Reagents: Hydrochloric Acid Solvents: Water 标题:The Synthesis Of Atomoxetine-Containing Carboxamides - Potential Human Carbonic Anhydrase Inhibitors 作者:Shetnev,Anton A.; Et Al 参考文献:American Chemical Science Journal 日期:2016 卷标:10(3) 页码:1-5]
115290-79-4 = 82248-59-7 反应条件:1.1 Solvents: Tetrahydrofuran 标题:Asymmetric Synthesis Of Both Enantiomers Of Tomoxetine And Fluoxetine. Selective Reduction Of 2,3-Epoxycinnamyl Alcohol With Red-Al 作者:Gao,Y.; Et Al 参考文献:Journal Of Organic Chemistry 日期:1988 卷标:53(17) 页码:4081-4]
115290-79-4 = 82248-59-7 反应条件:1.1 Solvents: Tetrahydrofuran,Water; 3 H,65 °C1.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether; Rt 标题:Regio- And Stereoselective Ring Opening Of Enantiomerically Enriched 2-Aryl Oxetanes And 2-Aryl Azetidines With Aryl Borates 作者:Bertolini,Ferruccio; Et Al 参考文献:Journal Of Organic Chemistry 日期:2008 卷标:73(22) 页码:8998-9007]
134619-78-6 = 82248-59-7 反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Ethanol 标题:A New Chemoenzymic Enantioselective Synthesis Of R-(-)-Tomoxetine,(R)- And (S)-Fluoxetine 作者:Kumar,Ashok; Et Al 参考文献:Tetrahedron Letters 日期:1991 卷标:32(16) 页码:1901-4]
114133-37-8 = 82248-59-7 反应条件:1.1 Reagents: Triphenylphosphine,Diethyl Azodicarboxylate Solvents: Diethyl Ether; -10 °C -> 0 °C1.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether 标题:Pd-Catalyzed Kinetic Resolution Of Benzylic Alcohols: A Practical Synthesis Of (R)-Tomoxetine And (S)-Fluoxetine Hydrochlorides 作者:Ali,Iliyas Sayyed; Et Al 参考文献:Tetrahedron Letters 日期:2002 卷标:43(31) 页码:5435-5436]
100306-34-1 = 82248-59-7 反应条件:1.1 Reagents: Triphenylphosphine,Diethyl Azodicarboxylate Solvents: Tetrahydrofuran; Rt; 14 H,Rt1.2 Solvents: Hexane; 30 Min,Reflux2.1 Solvents: Water; 3 H,130 °C; 130 °C -> Rt2.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether,Water; Rt 标题:A New Method For Synthesis Of Atomoxetine And Its Interaction With Azole-Containing Sulfonyl Chlorides 作者:Korsakov,M. K.; Et Al 参考文献:Zhurnal Organichnoi Ta Farmatsevtichnoi Khimii 日期:2013 卷标:11(4) 页码:38-41
专利号:US-9353057-B2 优先权日:2003-12-30 标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof 发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA 权利人:XENOPORT INC 摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.
专利号:US-9315483-B2 优先权日:2007-09-13 标题 :Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof 发明人:JONES ANDREW D; ZELLE ROBERT E; SILVERMAN I ROBERT 权利人:CONCERT PHARMACEUTICALS INC 摘要:The present invention provides a convenient and efficient process for the synthesis of d 2 -benzo[d][1,3]dioxoles.
专利号:US-12180182-B2 优先权日:2021-12-01 标题 :(Di)amination of activated allene compounds, derivatives thereof, and methods for synthesis of the same 发明人:DAI MINGJI 权利人:PURDUE RESEARCH FOUNDATION 摘要:One-pot synthesis methods for producing amines from activated allenes and derivatives thereof are provided, as well as the compounds produced thereby.
专利号:US-10456387-B2 优先权日:2011-11-29 标 题:Phacetoperane for treating of attention deficit hyperactivity disorder 发明人:KONOFAL ERIC; FIGADERE BRUNO 权利人:NLS PHARMA AG; NLS PHARMACEUTICS AG 摘要:The invention relates to the treatment of an attention deficit hyperactivity disorder (ADHD) with alpha-phenyl(piperidin-2-yl)methanol, or the pharmaceutically acceptable salts and esters thereof, in particular the acetate derivative, more particularly dextrophacetoperane. The invention additionally provides a method of synthesis of the (S,S) enantiomer of alpha-phenyl(piperidin-2-yl)methanol as well as a method of synthesis of dextrophacetoperane.
专利号:US-7507861-B2 优先权日:2004-06-28 标题:Process for the preparation of atomoxetine hydrochloride 发明人:CASTELLI EUGENIO; LO MONACO GIUSEPPE; MANTOVANI SILVIA; DAVERIO PAOLA; RIVA PAOLO; VAILATI ALESSANDRA; BIANCHI STEFANO 权利人:TEVA PHARM FINE CHEMICALS SRL 摘要:The present invention provides improved processes for the preparation of atomoxetine hydrochloride under reaction conditions that improve reaction yields and facilitate commercial synthesis. In particular, the invention is directed to the synthesis of atomoxetine HCl by adding HCl to a mixture of (R)-(−)-tomoxetine (S)-(+)-mandelate with an organic solvent, with or without a base and water.
专利号:US-7576211-B2 优先权日:2004-09-30 标题 :Synthesis of thienopyridinone compounds and related intermediates 发明人:DHANOA DALE S; BECKER OREN; NOIMAN SILVIA; CHEN DONGLI; MARANTZ YAEL; SHACHAM SHARON; HEIFETZ ALEXANDER; INBAL BOAZ; BAR-HAIM SHAY; MOHANTY PRADYUMNA; LOBERA MERCEDES; WU LAURENCE 权利人:EPIX DELAWARE INC 摘要:The invention relates to 5-HT receptor agonists and partial agonists. Novel thienopyridinone compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include Alzheimer's disease, cognition disorders, irritable bowel syndrome, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease, nonulcer dyspepsia, depression, anxiety, urinary incontinence, migraine, arrhythmia, atrial fibrillation, ischemic stroke, gastritis, gastric emptying disorders, feeding disorders, gastrointestinal disorders, constipation, erectile dysfunction, and respiratory depression. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.